Skip to main content
. 2023 Nov 30;23:1331. doi: 10.1186/s12913-023-10215-1

Table 3.

Outcomes at baseline vs. end of follow up among participants who enrolled in AMPATH prior to EAT (a pre/post comparison)

At EAT baseline N = 60 n (%, 95% CI) At end of EAT follow up N = 60 n (%, 95% CI) P-Valuea
Active in care at AMPATH 44 (73, 62–85) 53 (88, 80–96) 0.039
Initiated ART 56 (93, 87–100) 60 (100) 1.000
Had a viral load measurea 33 (55, 42–68) 50 (83, 74–93)  < 0.001
Virally suppressed at most recent viral load measurea 25 (42, 29–54) 38 (63, 51–76) 0.012

aWithin the 19 months before EAT, for equivalence with duration of EAT follow-up

P-value associated with McNemar’s Chi-square test statistic

Bold values indicate statistical significance